Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | PLK1 | P53350 | 2/20 | 0.34 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12038247 | 1.00 | CYP1A2 (0.41) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL12180026 | 0.97 | CYP1A2 (0.41) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL30101142 | 0.87 | CYP1A2 (0.54) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL2100060 | 0.87 | CYP1A2 (0.54) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL11520918 | 0.87 | CYP1A2 (0.54) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL823153 | 0.87 | CYP1A2 (0.54) | CYP1A2PLK1NEU3GAABRD4 | |
| SCHEMBL12180022 | 0.85 | CYP1A2 (0.38) | CYP1A2GAAMEN1KMT2A | |
| SCHEMBL17975105 | 0.84 | CYP1A2 (0.54) | CYP1A2MEN1GFERKMT2AHKDC1 | |
| SCHEMBL12037896 | 0.82 | CYP1A2 (0.36) | CYP1A2NEU3 | |
| SCHEMBL12038233 | 0.82 | ALDH1A1 (0.50) | CYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110294257-A1 | METHODS OF PROVIDING SEMICONDUCTOR LAYERS FROM AMIC ACID SALTS | KODAK AMERICAS LTD. | 2011-12-01 | — | — | US | disclosed |
| US-20110295010-A1 | AROMATIC AMIC ACID SALTS AND COMPOSITIONS | FPC INC. | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295010-A1 | AROMATIC AMIC ACID SALTS AND COMPOSITIONS | DDC, MYOC, TNNC1 | CYP1A2 679/4885PLK1 4819/4885NEU3 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.